Breast cancer overdiagnosis in stop-screen trials: More uncertainty than previously reported

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

(2020) Harry J. de Koning et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology

(2017) Theodora M Ripping et al.   JNCI-Journal of the National Cancer Institute

Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology

(2017) Theodora M Ripping et al.   JNCI-Journal of the National Cancer Institute

Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation

(2016) Heidi D. Nelson et al.   ANNALS OF INTERNAL MEDICINE

Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography

(2016) Gemma Jacklyn et al.   BRITISH JOURNAL OF CANCER

Revised estimates of overdiagnosis from the Canadian National Breast Screening Study

(2016) Cornelia J. Baines et al.   PREVENTIVE MEDICINE

Latent class instrumental variables: a clinical and biostatistical perspective

(2015) Stuart G. Baker et al.   STATISTICS IN MEDICINE

Lead Time and Overdiagnosis

(2014) S. G. Baker et al.   JNCI-Journal of the National Cancer Institute

Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer

(2014) Edward F. Patz et al.   JAMA Internal Medicine

Over-diagnosis estimate from The Independent UK Panel on Breast Cancer Screening is based on unsuitable data

(2013) Sisse Helle Njor et al.   JOURNAL OF MEDICAL SCREENING

The benefits and harms of breast cancer screening: an independent review

(2012)   LANCET

Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests

(2008) Stuart G Baker et al.   JOURNAL OF MEDICAL SCREENING